The American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH) have reviewed the latest research and developed evidence-based clinical guidelines about the use of epoetin (recombinant erythropoietin) for the treatment of cancer-related anemia. These guidelines are available online at ASCO?s website www.jco.org under ?Early Release,? and ASH?s website www.bloodjournal.org under ?First Edition Papers.?
Go to Previous Page
Go to Next Page